Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells
In: Molecular Metabolism ; volume 55, page 101410 ; ISSN 2212-8778, 2022
academicJournal
Zugriff:
Titel: |
Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells
|
---|---|
Autor/in / Beteiligte Person: | Trinh, Anne ; Khamari, Raeeka ; Fovez, Quentin ; Mahon, François-Xavier ; Turcq, Béatrice ; Bouscary, Didier ; Maboudou, Patrice ; Joncquel, Marie ; Coiteux, Valérie ; Germain, Nicolas ; Laine, William ; Dekiouk, Salim ; Jean-Pierre, Sandrine ; Maguer-Satta, Veronique ; Ghesquiere, Bart ; Idziorek, Thierry ; Quesnel, Bruno ; Kluza, Jerome ; Marchetti, Philippe ; Ligue Nationale Contre Le Cancer |
Link: | |
Zeitschrift: | Molecular Metabolism ; volume 55, page 101410 ; ISSN 2212-8778, 2022 |
Veröffentlichung: | Elsevier BV, 2022 |
Medientyp: | academicJournal |
DOI: | 10.1016/j.molmet.2021.101410 |
Schlagwort: |
|
Sonstiges: |
|